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Procoagulant activity in kidneys of normal and bacterial lipopolysac-
charide—treated rabbits. Fibrin formation in the kidney is frequently
associated with clinically—significant renal dysfunction. We therefore
measured and characterized the procoagulant activity (PCA) which is
present in normal kidneys and in kidneys of rabbits with the Shwartz-
man phenomenon induced by two injections of bacterial lipopolysac-
charide (LPS; E. coli LPS 055:B5,25 pg/kg and 50 tg/kg administered
24 hrs apart with rabbits sacrificed 12 hrs after the second injection).
PCA was measured in sonicated tissue by one—stage coagulation assay.
In normal kidneys the amounts of PCA in the inner medulla, outer
medulla and inner cortex were 18.2 3.2, 44.1 3.8 and 78.5 5.7
percent, respectively, of that in the outer cortex (N = 31). Glomeruli
(purified by the iron oxide magnetic method to greater than 95 percent
homogeneity) contained 21.6 8.8arbitrary units/pg protein compared
with tubular fragments which contained 13.9 2.6 U/sg protein (N =
9). In LPS-treated rabbits PCA (in units/sg) increased in outer cortex
from 33.7 3.9 (control) to 73.4 10.4 (LPS, P < 0.01), in inner cortex
from 26.7 2.9 (control) to 83.3 17 (LPS, P < 0.02), in outer medulla
from 12.9 2.4 (control) to 54.5 16.5 (LPS, P < 0.05), and in inner
medulla from 12.2 2.4 (control) to 32.1 4.9 (LPS, P < 0.01).
Glomerular PCA increased from 21.6 8.8 (control) to 88.8 20.7
(LPS) units/sg (P = 0.01), while tubular fragment preparation PCA
increased from 13.9 2.6 (control) to 44.6 12.7 (LPS) U/pg (P =
0.02) (N = 9 per group). PCA was thromboplastin—like as judged by
clotting assay using human deficient plasmas. Fibrin and monocytes
were present within capillaries of glomeruli of LPS-treated rabbits. In
contrast, isolated glomeruli incubated with LPS for six or 21 hours
showed no increase in PCA. We conclude that most of the PCA in
normal kidneys is in the cortex. The normal renal medulla contains only
small amounts of PCA. PCA is distributed to both glomeruli and
tubules. Following LPS injection PCA increased in all structures
examined, particularly in the glomeruli where extensive fibrin formation
had occurred. This increase in glomerular PCA may have been related
to the influx of mononuclear cells.
Intraglomerular fibrin deposits are a frequent finding associ-
ated with many forms of renal dysfunction including sepsis,
toxemia and peripartum acute renal failure, thrombotic
microangiopathies, malignant hypertension, scleroderma, renal
allograft rejection and glomerulonephritis [1—8]. In experimen-
tal models of renal injury intraglomerular fibrin deposition
occurs following injection of bacterial lipopolysaccharide (LPS)
[91 as well as following accumulation of glomerular antigen—
antibody complexes and binding of anti-GBM antibodies to the
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glomerular basement membrane [2, 11—141. The generalized
Shwartzman reaction induced by two doses of bacterial
endotoxin (LPS) given 24 hours apart has been used as a model
of endotoxemia, disseminated intravascular coagulation and
glomerular capillary thrombosis leading to renal cortical necro-
sis [9, 10]. The mechanisms responsible for the activation of the
coagulation system within the kidney are not yet fully under-
stood [8]. Several different types of cultured cells in vitro have
been shown to be capable of producing PCA following stimu-
lation by substances such as LPS, immune complexes, C5a or
monokines [15—22]. In particular monocytes are capable of
being induced by activated lymphocytes to produce not only
tissue factor but also activated Factor VII and a pro-
thrombinase which does not appear to be Factor Xa [16, 20, 211.
Cultured endothelial cells synthesize tissue factor in response
to LPS, interleukin I and Tumor Necrosis Factor [15, 22].
Recent studies have shown that glomeruli of rabbits with
nephrotoxic nephritis develop high levels of PCA at the time
that glomerular fibrin formation occurs [23, 241. In the present
study we have measured and characterized PCA in the kidney
in normal and LPS-treated rabbits to determine what the normal
distribution of PCA is, and to find out whether PCA increases in
vivo under conditions where intravascular fibrin formation
occurs in the kidney.
Methods
Normal renal tissues
Male New Zealand white rabbits weighing between 2 and 2.5
kg were used. Animals were allowed food and water ad libitum
before experiments. The animals were anesthetized with
pentobarbital 10 to 15 mg/kg intravenously. A midline laparot-
omy was performed, exposing the abdominal aorta and vena
cava, as well as the left kidney. After blunt dissection of the
main vessels, the aorta (above the level of the inferior mesen-
teric artery), and the inferior mesenteric artery were clamped
with hemostats. A gauge 14 over the needle teflon catheter
(Abbocath, Abbot Hospitals Inc., North Chicago, Illinois,
USA) was introduced into the abdominal aorta below the level
of the renal arteries in an upstream direction. The inferior vena
cava was then cut to allow fluid to escape, and 50 to 150 ml of
0.9% sterile saline solution was infused in order to flush the
blood out of both kidneys until they had completely blanched.
The pedicle of the right kidney was then clamped and 40 ml of
a 0.75% solution of iron oxide in 1% BSA was slowly injected
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1,000 x g for one minute to remove any strands of material that
might cause the fibrometer to read false fibrin strands) was
incubated at 37°C with 25 mrvi, CaCl2 and pooled, filtered,
normal human plasma (anticoagulated with sodium citrate
0.38%). The time taken for a fibrin strand to form was measured
using a fibrometer (Fibrosystem BBL, Benton Dickinson &
Co., Cockeysville, Maryland, USA). A standard curve was
* made using progressive dilutions of rabbit brain thromboplastin
(Sigma Chemical co., St. Louis, Missouri, USA), and the
results, expressed in seconds, plotted against dilution in a
log—log plot. This standard curve was linear between 20 seconds
** and 300 seconds and the slope was such that a twofold decrease
in clotting time represented approximately a 10-fold increase in
PCA. Similarly, increasing dilutions of the sonicates from
different rabbit kidney regions and structures were plotted, and
shown to be parallel to the standard curve. Samples were run in
duplicate, and the mean value of both determinations converted
into arbitrary units derived from the standard curve as previ-
ously described [231. The values obtained were factored by
protein concentration, and expressed as units/p.g of protein.
Human plasmas deficient in Factors XII, VII and X (George
King BioMedical Inc., Overland Park, Kansas, USA) were
used to further characterize glomerular and tubular PCA in a
one stage clotting assay as described above. Addition of iron
oxide to the coagulation assay did not change the clotting times.
Fig. 1. Comparison of the amount ofprocoagulant activity in d(fferent
regions of the kidney. PCA was measured as units per j.g in 31 different
experiments and expressed as percent of the value for outer cortex. The
values for inner and outer medulla were significantly different from the
value for inner cortex (* < 0.05, < 0.02).
through the abdominal catheter, turning the left kidney to a
greyish color. The animal was sacrificed by pentobarbital (50
mg/kg) and both kidneys were harvested and treated separately.
Samples of the right kidney were placed in formal—saline for
light microscopy; the rest was macroscopically separated into
four different regions: outer cortex, inner cortex, outer medulla,
and inner medulla. Each region was diced with a razor blade,
suspended in 2 ml of 0.15 M NaC1, sonicated for three minutes,
and frozen until assay. The cortex of the left kidney was
separated (easily identifiable by the iron particles trapped in the
glomeruli), minced and sieved through different sieves: 250 sm
copper, 250 j.m nylon, 180 pm copper, and 81 p.m nylon.
Glomeruli were collected from the top of the last screen. They
were rinsed with 0.9% saline into a beaker, which was then
placed on a magnet until the glomeruli adhered to the base of
the beaker (about 1 mm). The supernatant (containing the
tubular fragments) was poured off. This precedure was repeated
two to three times to obtain a clean glomerular preparation
(assessed under a light microscope to be more than 95%
glomeruli. Fig. 1). Both the glomerular sample as well as the
tubular fragment sample were then suspended in saline, soni-
cated and frozen at —30°C until assay.
Bacterial lipopolysaccharide—treated rabbits
A control and an experimental group consisted of five animals
each. The control group received no manipulation, whereas the
experimental group was injected with both a preparative and a
provocative dose of E. coli LPS (055:B5 Difco, Detroit, Mich-
igan, USA) of 25 pg/kg and 50 gIkg, respectively, administered
24 hours apart. Rabbits were sacrificed four to six hours after
the second injection.
Coagulation assay
The procoagulant activity of the samples was measured
employing a one—step coagulation assay using 100 jd volumes of
the following reagents: the sample for assay (precentrifuged at
Structural studies
For ultrastructural studies kidney tissue was excised from
paraffin blocks. Approximately 1 mm3 tissue samples were
deparaffinized in three changes of xylene with gentle rotation
over a twelve hour period. The samples were rehydrated
through graded alcohols to 0.1 M cacodylate buffer, pH 7.3, and
allowed to fix in cacodylate—buffered 4% glutaraldehyde for one
hour at 4°C. Postfixation in cacodylate—buffered 2% 0s04 for
one hour at 4° followed, and after two washes with 0.1 M
cacodylate buffer the samples were dehydrated through graded
alcohols to two changes of propylene oxide. The samples were
infiltrated with increasing concentrations of epon:araldite in
propylene oxide for approximately three hours and then em-
bedded in pure epon:araldite and cured overnight in a 65°C
oven. Ultrathin sections from these embedded samples were
prepared on an AO Ultracut ultramicrotome and stained with
uranyl acetate and lead citrate. Ultrastructure was examined on
a Phillips 400 transmission electron microscope. Light micro-
scopic analysis was performed from sections stained with
hemotoxylin and eosin.
Glomerular culture
Glomeruli were isolated from rabbit renal cortex as described
above except that the isolation was performed under sterile
conditions with washing steps done with sterile RPM! 1640
containing antibiotics (gentamycin 20 p,g/ml and penicillin 100
pJml). Glomeruli were then resuspended in the medium at a
concentration of 1000 glomeruli per ml. One ml (1000 glomeruli)
were placed in each well of a 24 well plate (Costar 3424, 16 mm
well diameter, Data Packaging, Cambridge, Massachusetts,
USA). LPS (E. coli 0111.4B, Difco) or interleukin-l (IL-i;
Cistron Technologies, Pinebrook, New Jersey, USA) was
added to wells to a final concentration of 100, 10, 1, 0.1 tg/ml of
LPS and 10 and 1 jzlml of IL-l. Plates were incubated in a CO2
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humidified incubator at 37°C for 6 hours or 21 hours. At the end
of this time the plates were frozen and thawed three times and
the procoagulant activity measured by recalcification time as
described above. Human renal cortex was obtained from sur-
gical specimens in the operating room. Kidneys removed for
carcinoma of the kidney had a normal pole resected and placed
in a sterile container on ice. The cortex was removed, minced
and the glomeruli sieved through 120 p.m nylon sieves. The
glomeruli were collected on 80 m sieves. They were washed
thoroughly in RPMI 1640 containing antibiotics (gentamycin 20
jg/ml, penicillin 100 /ml) and then handled in the same way as
rabbit glomeruli.
Miscellaneous
Iron oxide was prepared according to the method of Cook
and Pickering [251. Briefly, a solution of 20 g potassium nitrate
plus 2.6 g sodium hydroxide in 100 ml 95% oxygen—saturated
water was mixed with a solution of 9 g ferrous sulfate in 100 ml
95% oxygen—saturated water and brought to boil while con-
stantly stirred. The resulting iron oxide was allowed to precip-
itate on a magnet for two days, after which it was washed and
distilled water by mixture and decantation for five minutes
(always with the beaker on the magnet). Finally, the water was
discarded, the leftover sludge weighed, and a stock solution
prepared using 0.9% saline down to a final concentration of 50
mg/ml. Before infusion, it was diluted to a 0.75% solution in
BSA. Copper sieves were obtained from VWR (San Francisco,
California, USA) and the nylon screens from Tetko Inc.
(Elmsford, New York, USA).
Protein was measured using the Lowry et al method [261.
Statistical significance was tested utilizing Student's t-test.
Results
Distribution of PCA in the normal kindey
The PCA measured in various layers of normal kidney is
shown in Figure 1. The data are expressed as percent of the
outer cortex value to allow comparison of 31 studies done at
different times, with different standard curves. It is clear that
the most PCA is in the cortex and that least PCA is in the
medulla.
To further analyze the distribution of PCA within the cortex,
glomeruli and tubules were separated using the iron oxide
method (Methods). The glomerular and tubular preparations
used were greater than 95% free from contamination by tubules
and glomeruli respectively (Fig. 2). The PCA content of the
glomerular preparation was 21.6 8.8 U/1sg protein while that
of the tubular preparation was 13.9 2.6 U/pg protein (P =
0.41, N = 9). We conclude that from these data that most of the
PCA in the normal kidney is in the cortex where it is distributed
to both glomerular and tubular structures.
Distribution of PCA in kidneys of LPS-treated animals
Two groups of five rabbits were compared, one of which had
received two doses of LPS 24 hours apart to induce the
Shwartzman phenomenon as described in the Methods section.
The major histological abnormalities seen in the LPS-treated
rabbits are shown in Figure 3. Extensive fibrin formation was
seen within glomeruli capillaries, whereas the tubuli and
paratubular capillaries and the medulla were relatively spared.
Fig. 2. Glomerularpreparation isolated by the magnetic method using
iron oxide. The black material is iron oxide.
In addition to fibrin and erythrocytes, neutrophils and
monocytes were present in glomerular capillaries (Fig. 4).
These cells were present in the absence of fibrin and were
therefore not merely trapped by fibrin plugs.
The results of measurement of PCA in the different regions of
the kidney is shown in Figure 5. An increase in PCA in all layers
was observed although the relative distribution between cortex
and inner medulla was similar to that seen in normal kidney
with there being significantly less PCA in the inner medulla than
in the outer cortex (P < 0.05).
Glomerular and tubular preparations were also assayed for
PCA. Glomeruli from LPS-treated rabbits contained more PCA
than did glomeruli from control rabbits (88.8 20.7 vs. 21.6
8.8 units/tg; N = 9). This difference was statistically significant
(P = 0.01). The tubular fragment preparations from control and
LPS-treated rabbits contained 13.9 2.6 and 44.6 12.7
units/pg, respectively (P = 0.02). The difference between
glomeruli and tubular fragments in the control group was
not statistically significant (P = 0.41). For the LPS group
the glomerular PCA (88.8 20.7 units per g protein) tended
to be higher than tubular PCA (44.6 12.7 units per ig
protein), P = 0.07. The glomerular preparation was greater than
95% glomeruli. The tubular preparation was contaminated
by glomeruli (2 to 15%) probably because intraglomerular
thrombosis prevented ion oxide from embolizing into some
glomeruli. From these results we conclude that PCA in LPS-
treated rabbits increased markedly, and that more PCA was
present in glomeruli than tubules. This increased PCA was
associated with fibrin formation in glomeruli.
Characterization of PCA present in normal and LPS-treated
kidneys
The type of PCA present in normal and LPS-treated tissues
was analyzed by clotting assay using human plasmas deficient
in various coagulation factors. The results are shown in Table 1.
The clotting times of all preparations were markedly prolonged
by the absence of Factor VII but were not prolonged in
Hageman factor—deficient plasma. This finding that Factor VII
is required for PCA is consistent with the conclusion that
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Fig. 3. The major changes seen in kidneys of LPS-treated rabbits were in glomeruli where there was extensive fibrin formation within glomerular
capillaries, A. Light micrograph of section stained with hematoxylin and eosin. The arrows point to fibrin in giomerular capillaries (X 150). B.
Transmission electron micrograph part of a glomerulus of an LPS-treated rabbit. Arrows point to fibrin within glomerular capillaries (x 790). C.
Higher magnification shows the typical fibrillar appearance of fibrin (x 17,250).
thromboplastin was the major procoagulant signal in glomeruli
from both nonnal and LPS-treated rabbits.
Incubation of isolated glomeruli with LPS and interleukin-1
Rabbit glomeruli isolated by the magnetic method were
incubated with agents which stimulate tissue factor synthesis by
cultured endothelial cells. Rabbit glomeruli (1000 per ml) were
incubated with LPS (100, 10, 1, 0.1 g/ml) or interleukin-l (10,
1 piml) in RPMI 1640 for six hours (3 experiments) or 21 hours
(2 experiments). Glomeruli were then freeze—thawed three
times and assayed for PCA by clotting assay (Methods). No
increase in PCA in the presence of LPS or IL.! was detected in
any of the experiments (data not shown). In two experiments
sieve—purified human glomeruli were incubated with LPS (10, 1,
0.1 p,g/ml) and interleukin- 1 (10, 1 p/ml) in RPM! 1640 for six
hours and 21 hours. Glomeruli were freeze—thawed and assayed
for PCA. No increase in PCA in the presence of LPS or IL-i
was detected in either experiment (data not shown). We con-
clude from these data that glomerular cells in situ do not
respond to LPS or IL-i to produce tissue factor under the
conditions of these experiments. This is in contrast to experi-
ments carried out with cultured human umbilical—vein, endo-
thelial cells with the same reagents under the same conditions
were marked tissue factor production was induced [27].
Discussion
Previous studies have established that normal renal cortex
and glomeruli contain tissue factor—like procoagulant activity
[28, 29]. The purpose of this study was to examine the distri-
bution of PCA under normal and abnormal conditions in the
kidney. The finding that the normal renal medulla contains very
small amounts of PCA has also been reported previously [281
and is striking. It might possibly represent a protective mech-
anism in an area where blood flow is very slow. The normal
renal medulla also contains large amounts of fibrinolytic activity
[28, 30, 31] which might also function to reduce medullary fibrin
formation. Whether this low level of PCA and high level of
fibrinolytic activity is related to persistent bleeding into the
urinary tract seen under some circumstances is of potential
clinical interest.
The Shwartzman reaction is a model for glomerular
thrombosis and renal cortical necrosis similar to that seen in
septic abortion in man [32]. Many reports have examined the
effects of manipulations of the coagulation system on the
Shwartzman reaction [reviewed in 91. It is now well established
that anticoagulation (heparin, coumadin, ancrod) protects
against both glomerular thrombosis and cortical necrosis
whereas preventing fibrinolysis (with E-amino caproic acid)
enhances both glomerular fibrin accumulation and cortical
necrosis. Plasminogen activators are also protective [33—36].
Vasodilators protect from cortical necrosis but not glomerular
thrombosis [91. Intravenous injection of formed fibrin results in
accumulation of fibrin in the glomerulus, but only if fibrinolysis
was inhibited [37], and cross circulation experiments have
demonstrated accumulation of fibnn in glomeruli of the control
rabbits which had been prepared with a single injection of LPS
[38]. From these important studies we have the concept that
fibrin can form in the circulation, and accumulate on the
giomerular filter where, in the presence of vasocontriction, it
forms an effective plug preventing blood from reaching cortical
structures and thereby causing cortical necrosis. The fact that
glomerular fibrinolysis has been shown to be inhibited following
intravenous injection of LPS [39] probably as a result of platelet
or monocyte/macrophage release of the 50 kilodalton inhibitors
of plasminogen activation (PA inhibitor) PAl-i or PAI-2 [40—44]
supports this conclusion. However, accumulation of fibrin
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Fig. 4. Electron micrograph showing part of a glomerulus from an LPS-treated rabbit. Mononuclear cells (M) are present in glomerular
capillaries. No fibrin is present. The diagonal line is a cutting artefact (X 7,400).
which is formed outside the kidney on the glomerular filter
cannot be the only mechanism involved because intravascular
fibrin formation is also a feature of the localized Shwartzman
reaction.
To explain these events we need to understand how bacterial
lipopolysaccharides cause fibrin formation. There is no evi-
dence that the Hageman factor system plays an important role
[45, 461. The fact that leukocyte depletion prevents glomerular
thrombosis points to the leukocyte as the key cell [47, 481. It is
now well established that monocytes synthesize tissue factor
when incubated with LPS in the presence of serum [49, 50]. The
serum factor may be a complement protein [51]. However, the
situation is more complex, because monocytes also synthesize
Factor VII and a prothrombinase (not Factor X) when incu-
bated with LPS in the presence of lymphocytes [20, 21]. This
lymphokine—dependent interaction is HLA-restricted [18—211.
The rabbit hepatic macrophage also produces the prothrom-
binase molecule when incubated with LPS [52].
A second major potential source of tissue factor is the
endothelial cell [15, 53]. Cultured endothelial cells incubated
with LPS synthesizes tissue factor in the absence of serum.
They also facillitate fibrin formation by promoting coagulating
on the cell surface [54]. In addition the monokines Tumor
Necrosis Factor and interleukin-l also cause endothelial cells to
synthesize tissue factor [22], and the combination of interleukin
I and very small amounts of LPS is additive [27]. From these in
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Fig. 5. Comparison of PCA in djfferent regions of kidney from nomal() and LPS-treated (Ill) rabbits (N = 5 per group). The stars indicate
the significance of differences between control and LPS-treated animals(* < 0.05, < 0.02, < 0.01). Within the LPS-treated group the
value for the inner medulla was significantly lower than that for outer
cortex (P < 0.05).
vitro studies we therefore have a concept of several routes for
the synthesis of the procoagulant signal in response to LPS.
How does this information fit in with the Shwartzman model?
Leukocyte depletion studies in the rabbit which prevent both
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Test substance NHP XII-D VII-D X-D
Normal kidney
Outer cortex 57.0 61.1 122.3 >300
Inner cortex 66.7 69.8 113.9 >300
Outer medulla 67.6 62.6 197.9 >300
Inner medulla 173.7 192.9 269.0 >300
Thromboplastin 67.5 65.9 255.2 >300
Normal glomeruli
Preparation A 42.2 51.8 195.0 >300
Preparation B 62.0 69.9 205.0 >300
Thromboplastin 24.3 27.6 131.1 >300
LPS glomeruli
Preparation C 26.8 25.1 68.6 >300
Preparation D 32.4 ND 80.9 >300
Thromboplastin 22.9 20.8 147.8 297
Representative clotting times from experiments using human defi-
cient plasmas. Abbreviations are: NHP, normal citrated human plasma
pool; XII-D, Hageman factor—deficient plasma; VII-D, Factor VII-
deficient plasma; X-D, Factor X-deficient plasma; ND, not done. The
values given are the mean of duplicate measurements. Each experiment
included a rabbit brain thromboplastin control. Normal glomeruli were
glomeruli isolated from normal rabbit kidney. LPS glomeruli were
glomeruli isolated from kidneys of LPS-treated rabbits. The slope of
dilution of rabbit brain thromboplastin is such that a doubling of the
clotting time represents approximately a 10-fold decrease in amount of
PCA. The dilution curves of glomerular and kidney preparations were
parallel to that of the thromboplastin. Note that the absence of
Hageman factor did not prolong clotting times whereas the absence of
Factor VII did prolong clotting times.
glomerular thrombosis and cortical necrosis have used
cytotoxic agents that deplete both neutrophils and mononuclear
cells [47, 481. Although attention has been focussed on the
neutrophil [55—57] and some reports have suggested that the
neutrophil can synthesize tissue factor in vitro [57, 58] we have
not been able to confirm these findings [27]. Although
neutrophil preparations do synthesize tissue factor and can be
shown to enhance tissue factor production by cultured
endothelial cells, these effects are due to contamination of the
neutrophil preparation by small numbers of mononuclear cells
(<1%). At this time it therefore appears that mononuclear cells
(or macrophages) and/or endothelial cells are the most likely
source for the procoagulant signal following intravenous injec-
tion of LPS. This concept is supported by studies showing that
monocyte preparations from blood, marrow and spleen have
increased procoagulant activity following LPS injection in the
rabbit [59].
In this report we showed that renal cortical procoagulant
activity also increases after two LPS injection in the rabbit and
tha this increase appears to be in both glomerular and tubular
preparations, although glomeruli showed the higher levels. The
procoagulant activity was largely tissue factor—like. Since nor-
mal glomeruli contain both mononuclear cells of bone marrow
origin and endothelial cells either of these cell types might be
responsible without requiring additional help from circulating
cells. Indeed, endothelial cells themselves synthesize interleu-
kin-I when stimulated by LPS [60], and bacterial lipopolysac-
charides have been shown to accumulate in the kidney follow-
ing intravenous injection in the rabbit [611. However when we
incubated isolated glomeruli with LPS we detected no increase
in synthesis of tissue factor. We reasoned that the embolized
iron might prevent access of LPS to endothelial cells or
mesangium so we repeated the experiment in human glomeruli
isolated by sieving alone. Again we could detect no increase in
tissue factor synthesis. This result could still be artefactual due
to poor access of LPS to glomerular cells for some reason.
However, it tends to argue against intrinsic glomerular cells
being the source of enhanced tissue factor production. An
alternative explanation could be that monocytes from the
circulation had accumulated in glomerular capillaries or mesan-
gial region. This possibility is supported by ultrastructural
studies which showed that monocytes were present in glomer-
ular capillaries even when fibrin was not present. They were
therefore not merely trapped by fibrin plugs but appeared to
have adhered to glomerular endothelial cells. Recent studies
have emphasized the effect of LPS and monokines (IL-i and
TNF) on inducing expression on the endothelial cell surface of
both tissue factor and proteins which mediate adhesion of
leukocytes [62—64].
From these data we have a concept of mononuclear cells
accumulating in the glomerulus to provide a procoagulant signal
and possibly promoting a procoagulant signal by intrinsic
glomerular cells (endothelial cells or resident mesangial macro-
phages under the influence of LPS or monokines). This concept
fits in with recently published data from models of anti-GBM
disease in the rabbit. In one study using a passive model, the
increased glomerular tissue factor and fibrin formation could be
prevented by leukocyte depletion and partially restored by
infusion of peritoneal macrophages into the leukocyte—depleted
animals [24]. In our study using an active model, the procoag-
ulant signal corresponded with the appearance of fibrin in
Bowman's space and in glomerular capillaries and was associ-
ated with the influx of mononuclear cells [23]. Taken together
these studies suggest a role for local production of fibrin in
glomeruli in addition to fibrin forming elsewhere and becoming
deposited on the glomerular filter.
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